Ignite Creation Date:
2025-12-26 @ 10:37 AM
Ignite Modification Date:
2026-03-06 @ 10:09 PM
Study NCT ID:
NCT03651128
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2022-12-15
First Post:
2018-08-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety Study of bb2121 Versus Standard Regimens in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM)
Sponsor:
Celgene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-04-16
Start Date Type:
ACTUAL
Primary Completion Date:
2027-04-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-04-08
Completion Date Type:
ESTIMATED
First Submit Date:
2018-08-16
First Submit QC Date:
None
Study First Post Date:
2018-08-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-12-13
Last Update Post Date:
2022-12-15
Last Update Post Date Type:
ACTUAL